Celcuity logo

Celcuity Share Price Today

(NASDAQ: CELC)

Celcuity share price is $10.35 & ₹900.13 as on 6 Mar 2025, 2.30 'hrs' IST

$10.35

0.41

(4.12%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Celcuity share price in Dollar and Rupees. Guide to invest in Celcuity stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Celcuity, along with analyst recommendations, forecasts, and comprehensive financials.

Celcuity share price movements

  • Today's Low: $9.80
    Today's High: $10.39

    Day's Volatility :5.68%

  • 52 Weeks Low: $8.75
    52 Weeks High: $22.19

    52 Weeks Volatility :60.56%

Celcuity (CELC) Returns

PeriodCelcuity IncSector (Health Care)Index (Russel 2000)
3 Months
-21.24%
2.1%
0.0%
6 Months
-36.65%
-4.1%
0.0%
1 Year
-45.35%
2.2%
0.0%
3 Years
8.75%
11.8%
-11.6%

Celcuity (CELC) Key Statistics

in dollars & INR

Previous Close
$9.94
Open
$9.94
Today's High
$10.39
Today's Low
$9.8
Market Capitalization
$330.5M
Today's Volume
$92.7K
52 Week High
$22.188
52 Week Low
$8.75
Revenue TTM
$0.0
EBITDA
$-96.4M
Earnings Per Share (EPS)
$-2.59
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-77.47%

How to invest in Celcuity Stock (CELC) from India?

It is very easy for Indian residents to invest directly in Celcuity from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Celcuity stock in both Indian Rupees (INR) and US Dollars (USD). Search for Celcuity or CELC on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Celcuity or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Celcuity shares which would translate to 0.084 fractional shares of Celcuity as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Celcuity, in just a few clicks!

Returns in Celcuity (CELC) for Indian investors in Rupees

The Celcuity stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Celcuity investment value today

Current value as on today

₹61,862

Returns

₹38,138

(-38.14%)

Returns from Celcuity Stock

₹43,101 (-43.1%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Celcuity (CELC)

29%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Celcuity Stock from India on INDmoney has increased by 29% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Celcuity

  • Bvf Inc

    9.33%

  • Baker Bros Advisors LP

    7.21%

  • Soleus Capital Management, L.P.

    6.91%

  • Perceptive Advisors LLC

    6.36%

  • BlackRock Inc

    5.87%

  • Vanguard Group Inc

    4.45%

Analyst Recommendation on Celcuity

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Celcuity(by analysts ranked 0 to 5 stars)

Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
10
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Celcuity Stock (CELC)

What analysts predicted

Upside of 194.0%

Target:

$30.43

Current:

$10.35

Insights on Celcuity Stock (Ticker Symbol: CELC)

  • Price Movement

    In the last 7 days, CELC stock has moved up by 1.2%
  • CELC vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 107.7%
  • CELC vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 39.7%

Celcuity Technicals Summary

Sell

Neutral

Buy

Celcuity is currently in a neutral trading position according to technical analysis indicators.

Celcuity (CELC) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Celcuity Inc logo
-20.54%
-36.65%
-45.35%
8.75%
43.85%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Celcuity Inc logo
NA
NA
NA
-2.49
-0.77
-0.29
NA
4.03
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Celcuity Inc logo
Buy
$330.5M
43.85%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Celcuity

Celcuity Inc., a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, advanced or metastatic breast cancer, and metastatic castration resistant prostate cancer. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. The company was founded in 2011 and is headquartered in Minneapolis, Minnesota.
Organization
Celcuity
Employees
55
CEO
Mr. Brian F. Sullivan
Industry
Commercial Services

Management People of Celcuity

NameTitle
Mr. Brian F. Sullivan
Co-Founder, Chairman & CEO
Dr. Lance G. Laing Ph.D.
Co-Founder, Chief Science Officer, VP, Secretary & Director
Ms. Vicky Hahne CPA
Chief Financial Officer
Mr. Brent Eilefson
General Counsel
Ms. Sheri Smith
Acting Head of Clinical Operations
Mr. Igor Gorbatchevsky M.D.
Chief Medical Officer
Mr. Eldon C. Mayer III, M.B.A.
Chief Commercial Officer
Dr. Charlotte Moser M.B.A., M.D., M.Sc., Ph.D.
Senior Vice President of Clinical Development

Important FAQs about investing in CELC Stock from India :

What is Celcuity share price today?

Celcuity share price today stands at $10.35, Open: $9.94 ; Previous Close: $9.94 ; High: $10.39 ; Low: $9.80 ; 52 Week High: $22.19 ; 52 Week Low: $8.75.

The stock opens at $9.94, after a previous close of $9.94. The stock reached a daily high of $10.39 and a low of $9.80, with a 52-week high of $22.19 and a 52-week low of $8.75.

Can Indians buy Celcuity shares?

Yes, Indians can invest in the Celcuity (CELC) from India.

With INDmoney, you can buy Celcuity at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Celcuity at zero transaction cost.

How can I buy Celcuity shares from India?

It is very easy to buy Celcuity from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Celcuity (CELC) be purchased?

Yes, you can buy fractional shares of Celcuity with INDmoney app.

What are the documents required to start investing in Celcuity stocks?

To start investing in Celcuity, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Celcuity Stock (CELC)?

Today’s highest price of Celcuity (CELC) is $10.39.

Today’s lowest price of Celcuity (CELC) is $9.80.

What is today's market capitalisation of Celcuity?

Today's market capitalisation of Celcuity CELC is 330.5M

What is the 52 Week High and Low Range of Celcuity Stock (CELC)?

  • 52 Week High

    $22.19

  • 52 Week Low

    $8.75

What are the historical returns of Celcuity (CELC)?

  • 1 Month Returns

    -20.54%

  • 3 Months Returns

    -36.65%

  • 1 Year Returns

    -45.35%

  • 5 Years Returns

    43.85%

Who is the Chief Executive Officer (CEO) of Celcuity ?

Mr. Brian F. Sullivan is the current Chief Executive Officer (CEO) of Celcuity.